In the last trading session, 1.59 million shares of the Caredx Inc (NASDAQ:CDNA) were traded, and its beta was 2.23. Most recently the company’s share price was $14.18, and it changed around -$0.99 or -6.53% from the last close, which brings the market valuation of the company to $789.55M. CDNA currently trades at a discount to its 52-week high of $34.84, offering almost -145.7% off that amount. The share price’s 52-week low was $9.64, which indicates that the current value has risen by an impressive 32.02% since then.
Caredx Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.89. If we narrow it down even further, the data shows that 0 out of 8 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 3 recommended CDNA as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight. Caredx Inc is expected to report earnings per share of 0.12 for the current quarter.
Caredx Inc (NASDAQ:CDNA) trade information
Instantly CDNA has showed a red trend with a performance of -6.53% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 17.99 on recent trading dayincreased the stock’s daily price by 21.18%. The company’s shares are currently down -33.77% year-to-date, but still down -21.79% over the last five days. On the other hand, Caredx Inc (NASDAQ:CDNA) is -17.94% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $25, which translates to bulls needing to increase their stock price by 43.28% from its current value. Analyst projections state that CDNA is forecast to be at a low of $25 and a high of $25.
Caredx Inc (CDNA) estimates and forecasts
The year-over-year growth rate is expected to be 11.16%, up from the previous year.
Consensus estimates provided by 8 financial analysts predict the company will bring in an average of 90.72M in revenue for the current quarter. 8 analysts expect Caredx Inc to make 94.72M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 92.27M and 82.88M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -1.68%. Forecasts for the next quarter put sales growth at 14.28%.
Caredx Inc earnings are expected to increase by -137.81% in 2025, but the outlook is negative -11.41% per year for the next five years.
CDNA Dividends
Caredx Inc’s next quarterly earnings report is expected to be released in June.
BLACKROCK INC., with 10.1283% or 5.29 million shares worth $82.1 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
ARK ETF Trust-ARK Genomic Revolution ETF and BARON INVESTMENT Fd.S TRT -BARON DISCOVERY Fd. were the top two Mutual Funds as of Mar 31, 2025 . The former held 2.31 shares worth $32.72 million, making up 4.14% of all outstanding shares. On the other hand, BARON INVESTMENT Fd.S TRT -BARON DISCOVERY Fd. held roughly 1.68 shares worth around $23.84 million, which represents about 3.02% of the total shares outstanding.
